Cargando…
COVID-19: Discovery, diagnostics and drug development
Coronavirus disease 2019 (COVID-19) started as an epidemic in Wuhan in 2019, and has since become a pandemic. Groups from China identified and sequenced the virus responsible for COVID-19, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and determined that it was a novel coronavi...
Autores principales: | Asselah, Tarik, Durantel, David, Pasmant, Eric, Lau, George, Schinazi, Raymond F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543767/ https://www.ncbi.nlm.nih.gov/pubmed/33038433 http://dx.doi.org/10.1016/j.jhep.2020.09.031 |
Ejemplares similares
-
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
por: Ng, Teresa I., et al.
Publicado: (2022) -
Covid-19 and Artificial Intelligence: Genome sequencing, drug development and vaccine discovery
por: Abubaker Bagabir, Sali, et al.
Publicado: (2022) -
Drug metabolism in drug discovery and development
por: Zhang, Zhoupeng, et al.
Publicado: (2018) -
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens
por: Gish, Robert G, et al.
Publicado: (2022) -
Recent insights for the emerging COVID-19: Drug discovery, therapeutic options and vaccine development
por: Zhu, Yuefei, et al.
Publicado: (2021)